Clue, the #1 women-led period and cycle tracker, and Withings, a pioneer and global leader in connected health, are joining forces to empower women to regain control of their health. This new partnership sees the integration of health data from Withings ScanWatch 2 with Clue Plus to provide a more connected view of health and cycle data.
To mark the launch, they are offering a special bundle on Withings.com: ScanWatch 2 + a 1-year subscription to Clue Plus, Clue’s premium app experience, at a reduced price of €359,95 (75% off the annual Clue Plus membership)
The Withings ScanWatch 2 monitors 35 key health parameters, supporting energy levels, sleep quality, stress regulation, and cardiovascular health with a medical-grade ECG — and uniquely measures core body temperature through an advanced heat-flux sensor, going beyond surface skin readings. It combines the clinical precision of a health monitor with the timeless design of an analog watch. Thanks to its rechargeable battery, which lasts up to 35 days, it provides women with essential insights into how their bodies evolve day and night, especially during cycles and hormonal changes.
Clue Plus unlocks personalized cycle tracking, deeper analysis, advanced predictions, hormone insights, and features designed for pregnancy, perimenopause, and more. It also provides extended 12-month forecasting and expert-backed guidance from clinicians to help users turn their cycle into a powerful tool to discover patterns, stay on top of changes, and make informed health decisions.
Giving women a more connected view of their health
For too long, women’s health has been viewed through the lens of male physiology. Clinical research now shows that hormonal fluctuations have a profound impact on day-to-day well-being—from cycle phases to pregnancy to perimenopause.
This partnership aims to give every woman a better picture of their health by combining Clue’s easy, accurate cycle tracking with the everyday health insights from the ScanWatch 2 smartwatch. The integration provides users with a more complete picture of sleep, temperature, heart health, stress, and energy levels – giving women a more robust view of how their health changes with hormonal shifts during the cycle.
Rhiannon White, CEO of Clue, said: “Partnering with Withings was a natural step for us. Our two brands have a strong commitment to women’s health empowerment. We are aligned on science-based health tracking, with strict data privacy and compliance with CE and FDA medical-grade standards—ensuring women feel safe and supported in managing their menstrual health. ”
Aline Criton, Chief Medical Officer for Withings, said: “We are excited to partner with Clue to provide women worldwide a better view of their health—combining Clue’s powerful cycle insights with ScanWatch’s 24/7 health tracking to empower women to better understand the impact of cycles, pregnancy, and (peri)menopause on sleep, stress regulation, metabolism, cardiovascular health.”
Together, ScanWatch 2 and Clue Plus offer women a better understanding of their bodies and the impact of hormonal fluctuations on their health and well-being. ScanWatch 2 continuously tracks key data, day and night, which can change during the cycle or during certain phases such as pregnancy or perimenopause : 24/7 sleep, stress and its regulation, nighttime temperature fluctuations, as well as overall recovery and energy levels via its vitality indicator. Clue Plus allows users to record their emotions and symptoms throughout their menstrual cycle, to improve their well-being.
| Cycle and Period Tracking Together, ScanWatch 2 and Clue Plus offer women a comprehensive view of their health. By combining information from the Clue app with data on sleep, stress, activity, energy levels, and temperature measured by ScanWatch 2, women can better understand the impact of different phases of their cycle on their health and well-being. Pregnancy and Conception ScanWatch 2 and Clue Plus complement each other to support women on their fertility journey. ScanWatch 2 tracks key health indicators for this phase of life: stress level (heart rate variability), sleep quality, physical activity level— while Clue Conceive provides scientifically validated information from gynecologists-obstetricians and fertility experts, using a clinically validated algorithm to identify the most fertile days. Women thus make informed decisions to increase their chances of conception. Perimenopause ScanWatch 2 and Clue Perimenopause can help monitor key symptoms for this period: the gradual decrease in hormone levels can impact sleep and stress levels. Continuous temperature tracking by ScanWatch 2, for example, can identify the impact of temperature fluctuations and hot flashes on sleep. Clue Perimenopause provides key, science-backed information to better understand each symptom. |
The convergence of tech and brands 